FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $3,288,000 | -19.6% | 150,000 | +50.0% | 0.64% | -10.6% |
| Q3 2017 | $4,091,000 | +35.9% | 100,000 | 0.0% | 0.71% | +34.2% |
| Q2 2017 | $3,011,000 | -47.9% | 100,000 | -37.5% | 0.53% | -1.7% |
| Q1 2017 | $5,784,000 | +44.3% | 160,000 | +100.0% | 0.54% | -31.2% |
| Q4 2016 | $4,009,000 | -4.5% | 80,000 | 0.0% | 0.79% | +2.2% |
| Q3 2016 | $4,199,000 | +12.8% | 80,000 | -11.1% | 0.77% | -3.3% |
| Q2 2016 | $3,721,000 | -22.5% | 90,000 | -23.9% | 0.80% | -21.1% |
| Q1 2016 | $4,802,000 | -2.1% | 118,199 | 0.0% | 1.01% | +4.5% |
| Q4 2015 | $4,905,000 | +169.7% | 118,199 | 0.0% | 0.96% | +174.1% |
| Q3 2015 | $1,819,000 | -38.0% | 118,199 | 0.0% | 0.35% | -15.6% |
| Q2 2015 | $2,936,000 | -57.2% | 118,199 | -60.6% | 0.42% | -56.0% |
| Q1 2015 | $6,855,000 | -15.4% | 300,000 | 0.0% | 0.95% | -14.1% |
| Q4 2014 | $8,100,000 | – | 300,000 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|